Baidu
map

护理专业医疗质量控制指标(2020年版)

2020-08-20 中华人民共和国国家卫生健康委员会 卫健委

质控指标体系是医疗质量管理与控制体系的重要组成部分。构建科学、规范的医疗质控指标体系对加强科学化、精细化医疗质量管理,促进医疗质量持续改进具有重要意义。近年来,我委陆续制定印发了《三级综合医院医疗质量

中文标题:

护理专业医疗质量控制指标(2020年版)

发布日期:

2020-08-20

简要介绍:

质控指标体系是医疗质量管理与控制体系的重要组成部分。构建科学、规范的医疗质控指标体系对加强科学化、精细化医疗质量管理,促进医疗质量持续改进具有重要意义。近年来,我委陆续制定印发了《三级综合医院医疗质量管理与控制指标(2011年版)》、国家限制类技术质控指标、单病种质量控制指标,对促进相关专业的医疗质量管理工作发挥了重要作用。为进一步充实完善医疗质量管理与控制指标体系,我委在前期工作的基础上,组织相关专业国家质控中心制定了一系列质控指标,于近期印发了呼吸内科、产科、神经系统疾病、肾病等专业相关病种或技术的医疗质量控制指标。按照工作安排,现印发《药事管理专业和护理专业医疗质量控制指标(2020年版)》。
  各级各类医疗机构要结合自身实际情况,充分利用各项质控指标和各种医疗质量管理工具开展自我管理,不断提高医疗质量水平,保障医疗安全,并按要求做好相关指标信息的上报工作。各级卫生健康行政部门要根据质控工作需要,在国家发布的质控指标基础上,结合辖区内实际情况,进一步完善、细化、扩充相关质控指标,加强对辖区内医疗机构的培训和指导,强化指标应用,促进医疗机构持续提升医疗质量。国家卫生健康委将采用信息化手段加强相关信息收集、分析,通过年度《国家医疗服务与质量安全报告》等形式定期反馈,并将医疗机构有关质量情况纳入医院等级评审体系。

相关资料下载:
[AttachmentFileName(sort=1, fileName=11.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e10c91c0021a85bd, title=护理专业医疗质量控制指标(2020年版), enTitle=, guiderFrom=卫健委, authorId=0, author=, summary=质控指标体系是医疗质量管理与控制体系的重要组成部分。构建科学、规范的医疗质控指标体系对加强科学化、精细化医疗质量管理,促进医疗质量持续改进具有重要意义。近年来,我委陆续制定印发了《三级综合医院医疗质量, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Aug 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span style="color: #484848;">质控指标体系是医疗质量管理与控制体系的重要组成部分。构建科学、规范的医疗质控指标体系对加强科学化、精细化医疗质量管理,促进医疗质量持续改进具有重要意义。近年来,我委陆续制定印发了《三级综合医院医疗质量管理与控制指标(2011年版)》、国家限制类技术质控指标、单病种质量控制指标,对促进相关专业的医疗质量管理工作发挥了重要作用。为进一步充实完善医疗质量管理与控制指标体系,我委在前期工作的基础上,组织相关专业国家质控中心制定了一系列质控指标,于近期印发了呼吸内科、产科、神经系统疾病、肾病等专业相关病种或技术的医疗质量控制指标。按照工作安排,现印发《药事管理专业和护理专业医疗质量控制指标(2020年版)》。</span><br style="color: #484848;" /><span style="color: #484848;">  各级各类医疗机构要结合自身实际情况,充分利用各项质控指标和各种医疗质量管理工具开展自我管理,不断提高医疗质量水平,保障医疗安全,并按要求做好相关指标信息的上报工作。各级卫生健康行政部门要根据质控工作需要,在国家发布的质控指标基础上,结合辖区内实际情况,进一步完善、细化、扩充相关质控指标,加强对辖区内医疗机构的培训和指导,强化指标应用,促进医疗机构持续提升医疗质量。国家卫生健康委将采用信息化手段加强相关信息收集、分析,通过年度《国家医疗服务与质量安全报告》等形式定期反馈,并将医疗机构有关质量情况纳入医院等级评审体系。</span></p>, tagList=[TagDto(tagId=21759, tagName=医疗质量)], categoryList=[CategoryDto(categoryId=33, categoryName=政策与人文, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其它, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7772, appHits=347, showAppHits=0, pcHits=744, showPcHits=7423, likes=2, shares=42, comments=29, approvalStatus=1, publishedTime=Thu Aug 05 07:44:07 CST 2021, publishedTimeString=2020-08-20, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Wed Aug 04 22:20:21 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 16:11:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=11.pdf)])
11.pdf
下载请点击:
评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214448, encodeId=bf091214448e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:16:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204575, encodeId=a06f12045e5e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Mon Mar 21 11:41:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192543, encodeId=da0511925431e, content=规范值得建立, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Feb 11 22:50:38 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190991, encodeId=bad8119099157, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Tue Feb 08 11:44:49 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185237, encodeId=0d1a118523eba, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35205712693, createdName=ms5000001553076211, createdTime=Mon Jan 17 16:45:10 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-04-26 doufangyan

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214448, encodeId=bf091214448e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:16:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204575, encodeId=a06f12045e5e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Mon Mar 21 11:41:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192543, encodeId=da0511925431e, content=规范值得建立, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Feb 11 22:50:38 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190991, encodeId=bad8119099157, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Tue Feb 08 11:44:49 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185237, encodeId=0d1a118523eba, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35205712693, createdName=ms5000001553076211, createdTime=Mon Jan 17 16:45:10 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-03-21 ms4000000919175717

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214448, encodeId=bf091214448e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:16:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204575, encodeId=a06f12045e5e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Mon Mar 21 11:41:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192543, encodeId=da0511925431e, content=规范值得建立, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Feb 11 22:50:38 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190991, encodeId=bad8119099157, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Tue Feb 08 11:44:49 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185237, encodeId=0d1a118523eba, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35205712693, createdName=ms5000001553076211, createdTime=Mon Jan 17 16:45:10 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-11 一己怀

    规范值得建立

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214448, encodeId=bf091214448e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:16:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204575, encodeId=a06f12045e5e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Mon Mar 21 11:41:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192543, encodeId=da0511925431e, content=规范值得建立, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Feb 11 22:50:38 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190991, encodeId=bad8119099157, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Tue Feb 08 11:44:49 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185237, encodeId=0d1a118523eba, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35205712693, createdName=ms5000001553076211, createdTime=Mon Jan 17 16:45:10 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-08 ms1000000237784199

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214448, encodeId=bf091214448e3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:16:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204575, encodeId=a06f12045e5e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Mon Mar 21 11:41:44 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192543, encodeId=da0511925431e, content=规范值得建立, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Fri Feb 11 22:50:38 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190991, encodeId=bad8119099157, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfed5431582, createdName=ms1000000237784199, createdTime=Tue Feb 08 11:44:49 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185237, encodeId=0d1a118523eba, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35205712693, createdName=ms5000001553076211, createdTime=Mon Jan 17 16:45:10 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 ms5000001553076211

    已学习

    0

Baidu
map
Baidu
map
Baidu
map